Which statement is the scientific rationale for administering the biologic response modifier interferon (Intron A) to a client diagnosed with hepatitis C?
1. Intron A suppresses cell proliferation in proliferative diseases.
2. Intron A decreases the production of cytotoxic macrophages.
3. Intron A increases the production of suppressor genes.
4. Intron A reprograms virus-infected cells to inhibit virus replication.
Already registered? Login
Not Account? Sign up
Enter your email address to reset your password
Back to Login? Click here